These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists. Prasad SR; Jagirdar J J Comput Assist Tomogr; 2008; 32(1):1-3. PubMed ID: 18303280 [TBL] [Abstract][Full Text] [Related]
5. Detection of iron deposition in dermal fibrocytes is a useful tool for histologic diagnosis of nephrogenic systemic fibrosis. Miyamoto J; Tanikawa A; Igarashi A; Hataya H; Kobayashi K; Ikegami M; Sotome A; Nagai Y; Kameyama K; Ishiko A Am J Dermatopathol; 2011 May; 33(3):271-6. PubMed ID: 21389836 [TBL] [Abstract][Full Text] [Related]
6. Implications of NSF-active and NSF-inert in nephrogenic systemic fibrosis. Wiginton CD AJR Am J Roentgenol; 2008 Dec; 191(6):1864-6. PubMed ID: 19020261 [No Abstract] [Full Text] [Related]
7. Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST study. Janus N; Launay-Vacher V; Karie S; Clement O; Ledneva E; Frances C; Choukroun G; Deray G Eur J Radiol; 2010 Feb; 73(2):357-9. PubMed ID: 19128909 [TBL] [Abstract][Full Text] [Related]
8. Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling. Deng A; Martin DB; Spillane A; Chwalek J; St Surin-Lord S; Brooks S; Petrali J; Sina B; Gaspari A; Kao G J Cutan Pathol; 2010 Feb; 37(2):204-10. PubMed ID: 19341434 [TBL] [Abstract][Full Text] [Related]
9. Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patients. Abujudeh HH; Rolls H; Kaewlai R; Agarwal S; Gebreananya ZA; Saini S; Schaefer PW; Kay J J Magn Reson Imaging; 2009 Dec; 30(6):1335-40. PubMed ID: 19937927 [TBL] [Abstract][Full Text] [Related]
10. Findings of osseous sclerotic bodies: a unique sequence of cutaneous bone formation in nephrogenic systemic fibrosis. Kartono F; Basile A; Roshdieh B; Schwimer C; Shitabata PK J Cutan Pathol; 2011 Mar; 38(3):286-9. PubMed ID: 20726931 [TBL] [Abstract][Full Text] [Related]
11. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis in 2 patients with end-stage renal disease on hemodialysis. Kim RH; Ma L; Hayat SQ; Ahmed MM J Clin Rheumatol; 2006 Jun; 12(3):134-6. PubMed ID: 16755242 [TBL] [Abstract][Full Text] [Related]
12. Balance of profibrotic and antifibrotic [corrected] signaling in nephrogenic systemic fibrosis skin lesions. Schieren G; Gambichler T; Skrygan M; Burkert B; Altmeyer P; Rump LC; Kreuter A Am J Kidney Dis; 2010 Jun; 55(6):1040-9. PubMed ID: 20430497 [TBL] [Abstract][Full Text] [Related]
16. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation. Wilford C; Fine JD; Boyd AS; Sanyal S; Abraham JL; Kantrow SM Am J Dermatopathol; 2010 Feb; 32(1):71-5. PubMed ID: 19940755 [TBL] [Abstract][Full Text] [Related]